NEXSTIM PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.27 EUR | +1.79% |
|
0.00% | -22.79% |
| Feb. 28 | Nexstim Receives NBS System 5 Order from Neurosurgery Customer in Germany | CI |
| Feb. 27 | Transcript : Nexstim Plc, 2023 Earnings Call, Feb 27, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Companyâs systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
Calendar
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.23
EUR
Average target price
3
EUR
Spread / Average Target
+34.53%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.79% | 16.09M | |
| +2.43% | 207B | |
| +1.82% | 175B | |
| +8.43% | 132B | |
| +16.18% | 99.1B | |
| -3.42% | 60.89B | |
| +12.41% | 52.04B | |
| -6.33% | 45.48B | |
| -4.04% | 38.81B | |
| +9.56% | 38.77B |
- Stock Market
- Equities
- NXTMH Stock
- News Nexstim Plc
- Nexstim Invests In US-Based PNC Management Services
